Organization
Hospital Virgen del Rocio, Seville, Spain
2 abstracts
Abstract
Non-basal subtype defined by FOXC1 expression as an independent predictor of capecitabine efficacy in the triple negative breast cancer GEICAM/2003-11_CIBOMA/2004-01 trial.Org: Onconostic Technologies, Evanston, IL, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Instituto Nacional de Enfermedades Neoplásicas (INEN), Universidad Ricardo Palma, Instituto Nacional del Cáncer; LACOG (Latin American Cooperative Oncology Group), Hospital Amaral Carvalho; LACOG (Latin American Cooperative Oncology Group),
Abstract
A phase 2 multi-arm study of magrolimab in combination with docetaxel in patients with locally advanced or metastatic solid tumors: ELEVATE Lung and UC.Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Rogel Cancer Center, University of Michigan, Huntsman Cancer Center, Oregon Health and Science University, Hospital Virgen del Rocio, Seville, Spain,